The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

White Papers
AHRMM17 CQO Summit White Paper
In 2014, AHRMM hosted the first Cost, Quality, and Outcomes (CQO) Summit to bring healthcare thought leaders together to discuss particular s
Supply Chain Strategies & Solutions Article
What I've Learned From Alice
Supply Chain Strategies & Solutions Article
Farmers Relied On The Farmer's Almanac To Guide Their Decisions. What Do You Rely On?
Data is becoming as much of an asset to an organization as its people.
Case Studies
Ochsner Health System Boosts Immunization Rates Among Ambulatory Patients
Organization Overview
Case Studies
Centura Health’s Practice Variation Reduction Reduces Costs, Improves Quality, and Boosts Financial Outcomes
Organization Overview
Case Studies
Intermountain Healthcare Drives Heart Healthiness Within Its Community
Organization Overview